SS Innovations Promotes Dr. Vishwa Srivastava to President, Appoints Gary Lo as CFO to Drive Global Expansion

SS Innovations International (NASDAQ: SSII) has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as CFO, strengthening its leadership team as it pursues U.S. and global expansion for its SSi Mantra surgical robotic system.

Chicago Metrowire Staff
••Healthcare
SS Innovations Promotes Dr. Vishwa Srivastava to President, Appoints Gary Lo as CFO to Drive Global Expansion

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer. The leadership changes come as the company advances international expansion plans for its SSi Mantra surgical robotic system and navigates regulatory processes in key markets.

Dr. Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building the U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning, and strategic growth. His appointment is expected to bolster the company’s financial strategy as it scales operations and seeks to capitalize on growth opportunities in the surgical robotics market.

The leadership moves are significant because they position SS Innovations to accelerate its expansion into the U.S. and other global markets. The company is currently responding to questions from the U.S. Food and Drug Administration (FDA) regarding its 510(k) premarket notification for the SSi Mantra system while pursuing CE marking certification in the European Union. These regulatory milestones are critical for commercializing the SSi Mantra in major markets and could substantially broaden the company’s addressable customer base. The SSi Mantra is a modular, multi-arm surgical robotic system designed to make robotic surgery more affordable and accessible. It has been clinically validated in India in more than 190 different types of surgical procedures, including cardiac surgery, and utilizes over 40 different types of robotic endo-surgical instruments. The system’s advanced features, such as an open-faced ergonomic surgeon command center and a large 3D 4K monitor, are intended to enhance surgical precision and efficiency.

In addition to regulatory progress, SS Innovations is finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months. This pipeline could provide further growth catalysts and demonstrate the company’s commitment to innovation in surgical robotics. For investors, the strengthened leadership team and ongoing regulatory efforts are key indicators of the company’s potential to execute its strategy and capture share in the global surgical robotics market. The full press release can be viewed at https://nnw.fm/dX3qc.

For more information about SS Innovations, visit the company’s website at ssinnovations.com or its LinkedIn page. The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII.

This news is distributed by NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is part of the Dynamic Brand Portfolio at IBN, which offers access to a vast network of wire solutions via InvestorWire and editorial syndication to 5,000+ outlets, among other services. For full terms of use and disclaimers, please visit https://www.NetworkNewsWire.com/Disclaimer.

Blockchain Registration

QR Code for Blockchain Registration